Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Clinical Psychopharmacology

• Publication date

  2003-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00004850-200303000-00001PMID 12598816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo

  2005cited by this paper
• Acetyl-L-carnitine for dementia.

  2003cited by this paper
• Education Bias in the Mini-Mental State Examination

  2001influential reference
• The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.

  2000influential reference
• A 1-year controlled trial of acetyl-l-carnitine in early-onset AD

  2000cited by this paper
• Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Functional and Quality of Life Scales

  2000influential reference
• Influencias de la edad y de la escolaridad en el examen breve del estado mental (Mini-Mental State Examination) en una población hispano-hablante

  1999cited by this paper
• Neuropsychometric Tests in Cross Sectional and Longitudinal Studies - A Regression Analysis of ADAS - Cog, SKT and MMSE

  1999influential reference
• [Dementia screening in routine clinical practice. A comparative analysis of MMSE, SIDAM and ADAS].

  1998influential reference
• Establishing the limits and characteristics of normal age-related cognitive decline.

  1997cited by this paper
• THE CLOCK DRAWING TEST FOR DEMENTIA OF THE ALZHEIMER'S TYPE: A COMPARISON OF THREE SCORING METHODS IN A MEMORY DISORDERS CLINIC

  1997influential reference
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• EDUCATION AND DECLINE IN COGNITIVE PERFORMANCE: COMPENSATORY BUT NOT PROTECTIVE

  1997cited by this paper
• A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease

  1996influential reference
• Does education level determine the course of cognitive decline?

  1996cited by this paper
• Mini mental state examination: influence of sociodemographic, environmental and behavioral factors and vascular risk factors.

  1996cited by this paper
• Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients.

  1995influential reference
• [Use of behavioral scales in the diagnosis of dementia in the aged].

  1995influential reference
• Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

  1995influential reference
• Factors determining interrater agreement with rating global change in dementia: The cibic‐plus

  1995cited by this paper
• Cognitive deficits in ischemic strokes: psychometric, electrophysiological and cranial tomographic assessment.

  1994influential reference
• Acetyl-L-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats.

  1994cited by this paper
• Acetyl-L-carnitine treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following total fimbria-fornix transection.

  1994cited by this paper
• Are age and education independent correlates of the Mini-Mental State Exam performance of community-dwelling elderly?

  1993cited by this paper
• Effect of acetyl-l-carnitine on extracellular amino acid levels in vivo in rat brain regions

  1993cited by this paper
• Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

  1993influential reference
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.

  1992cited by this paper
• In vivo effect of acetyl-L-carnitine on succinate oxidation, adenine nucleotide pool and lipid composition of synaptic and non-synaptic mitochondria from cerebral hemispheres of senescent rats.

  1992cited by this paper
• The Mini‐Mental State Examination: A Comprehensive Review

  1992influential reference
• Misclassification of dementia by the mini-mental state examination--are education and social class the only factors?

  1992cited by this paper
• Alzheimer's disease: correlational analysis of three screening tests and three behavioral scales

  1992influential reference
• [Comparison of several screening instruments for dementia].

  1991influential reference
• Effect of Education on the Mini‐Mental State Examination as a Screening Test for Dementia

  1991influential reference
• Long‐term acetyl‐L‐carnitine treatment in Alzheimer's disease

  1991influential reference
• Acetyl‐L‐Carnitine in dementia

  1991cited by this paper
• Acetyl-1-carnitine. 2: Effects on learning and memory performance of aged rats in simple and complex mazes.

  1990cited by this paper
• Acetyl-l-carnitine as a precursor of acetylcholine

  1990cited by this paper
• Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.

  1990cited by this paper
• Acetyl-L-carnitine in the treatment of mildly demented elderly patients.

  1990cited by this paper
• Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.

  1990cited by this paper
• Aging brain: effect of acetyl-L-carnitine treatment on rat brain energy and phospholipid metabolism. A study by 31P and 1H NMR spectroscopy.

  1990cited by this paper
• Acetyl-l-carnitine 1: Effects on mortality, pathology and sensory-motor performance in aging rats

  1990cited by this paper
• Uptake of acetyl-l-carnitine in the brain

  1989cited by this paper
• Alzheimer's Disease Assessment Scale (ADAS).

  1988cited by this paper
• Blessed-Roth Dementia Scale (DS).

  1988influential reference
• Multicenter clinical placebo‐controlled study with acetyl‐l‐carnitine (LAC) in the treatment of mildly demented elderly patients

  1988cited by this paper
• Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA.

  1988cited by this paper
• The blessed dementia scale as a screening test for dementia

  1988influential reference
• Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus.

  1986cited by this paper
• Principles of Biochemistry

  1984cited by this paper
• Summing Up: The Science of Reviewing Research Harvard University Press: Cambridge, MA, 1984, xiii+191 pp

  1984cited by this paper
• The Global Deterioration Scale for assessment of primary degenerative dementia.

  1982influential reference
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975influential reference
• An Age

  1883influential reference

• Glucose hypometabolism and hyperphosphorylated Tau synergistically drive neuronal necroptosis

  2026cites this paper
• Fluorinated Carnitine Derivatives as Tools to Visualise Carnitine Transport and Metabolism

  2025cites this paper
• Effects of lacto-vegetarian and vegan diets on glycemic responses and metabolite profiles in healthy adults: A randomized trial using continuous glucose monitoring and targeted metabolomics.

  2025cites this paper
• Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer’s Disease? A Review of Recent Pertinent Observations from Molecular Biology

  2025cites this paper
• Impact Induces Phagocytic Defect in Reactive Microglia

  2025cites this paper
• Regenerative Medicine in the Treatment of Alzheimer’s Disease: A Narrative Review

  2025cites this paper
• Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism

  2025cites this paper
• Impact of coffee-derived chlorogenic acid on cognition: a systematic review and meta-analysis.

  2024cites this paper
• Acetyl-L-Carnitine Aids in Preservation of Cholinergic Neurons and Memory in the Drosophila melanogaster Model of Alzheimer's Disease.

  2024cites this paper
• RETRACTED ARTICLE: Effect of whey protein-derived decapeptide on mood status and blood variables in healthy adults: a randomized, double-blind, placebo-controlled cross-over trial

  2024cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• Effects of academic dishonesty policy reminder on university students’ exam cheating – a double-blind randomized controlled experimental field study

  2023cites this paper
• Outcomes and Factors Affecting Transcranial Direct Current Stimulation in Alzheimer's Disease Patients: A Systematic Review.

  2023cites this paper
• The effects of L-carnitine supplementation on lipid profiles in adults: A systematic review and dose-response meta-analysis

  2023cites this paper
• Targeting Skeletal Muscle Dysfunction With L-Carnitine for the Treatment of Patients With Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use.

  2023cites this paper
• Association Between Plasma L-Carnitine and Cognitive Impairment in Patients with Acute Ischemic Stroke

  2022cites this paper
• Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-World Data

  2022cites this paper
• The relationship between cognitive impairment and fatty acids and carnitine in hemodialysis patients.

  2022cites this paper
• Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation

  2022cites this paper
• Carnitine and its Derivatives as a Potential Option for Cardiovascular, Neurologic and Metabolic Complications of COVID-19

  2022cites this paper
• Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

  2022cites this paper
• [Asthenic syndrome in general therapeutic practice].

  2022cites this paper
• Myo-Inositol Levels in the Dorsal Hippocampus Serve as Glial Prognostic Marker of Mild Cognitive Impairment in Mice

  2021cites this paper
• Propionate and Alzheimer’s Disease

  2021cites this paper
• The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer’s Disease

  2021cites this paper
• Neuroprotective Effects of Carnitine and Its Potential Application to Ameliorate Neurotoxicity.

  2021cites this paper
• Nutrition, Gut Microbiota, and Alzheimer's Disease

  2021cites this paper
• ACETYL-L-CARNITINE IN CHRONIC PAIN: A NARRATIVE REVIEW.

  2021cites this paper
• Improvement of cognitive performance by a nutraceutical formulation: Underlying mechanisms revealed by laboratory studies.

  2021cites this paper
• Medicinal herbs and nutritional supplements for dementia therapy: potential therapeutic targets and clinical evidence.

  2021cites this paper
• A predictive framework based on brain volume trajectories enabling early detection of Alzheimer's disease

  2021cites this paper
• Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update

  2020influential citation
• Alzheimer’s Disease

  2020cites this paper
• L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder

  2020cites this paper
• Polymeric Nanoparticle Versus Liposome Formulations: Comparative Physicochemical and Metabolomic Studies as l-Carnitine Delivery Systems

  2020cites this paper
• An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases

  2020cites this paper
• ALSUntangled 53: Carnitine supplements

  2020cites this paper
• Potential therapeutic role of carnitine and acetylcarnitine in neurological disorders.

  2020cites this paper
• Risk Factors for Alzheimer’s Disease

  2020cites this paper
• Nutritional interventions for the prevention of cognitive impairment and dementia in developing economies in East-Asia: a systematic review and meta-analysis

  2020cites this paper
• Carnitine promotes recovery from oxidative stress and extends lifespan in C. elegans

  2020cites this paper
• Use of Acetyl-L-Carnitine in Gerontological Practice

  2019cites this paper
• The Effects on the Cognitive Function of Healthy Volunteers of a Combination of Acetyl-L-Carnitine, Vinpocetine and Huperzine A Administered Over 28 Days

  2019cites this paper
• A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease

  2019cites this paper
• [Augmentation with carnicetine for late depression].

  2019cites this paper
• Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials.

  2019cites this paper
• Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta‐analysis involving 826 patients based on 10 randomized controlled trials

  2018cites this paper
• Effects of acetyl-l-carnitine in diabetic neuropathy and other geriatric disorders

  2018cites this paper
• Chapter 11 – Alzheimer Disease

  2018cites this paper
• A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease

  2018cites this paper
• Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders

  2018cites this paper
• The impact of non-pharmacological treatment on symptom reduction and progression of mild cognitive impairment to dementia

  2018cites this paper
• [The therapeutic potential of acetyl-L-carnitine in the treatment of cognitive and depressive disorders in the elderly].

  2018cites this paper
• ALCAR promote adult hippocampal neurogenesis by regulating cell‐survival and cell death‐related signals in rat model of Parkinson's disease like‐phenotypes

  2017cites this paper
• [The use of acetyl-L-carnitine in gerontological practice].

  2017cites this paper
• Cerebral Perfusion Changes after Acetyl-L-Carnitine Treatment in Early Alzheimer's Disease Using Single Photon Emission Computed Tomography

  2017cites this paper
• L-carnitine for cognitive enhancement in people without cognitive impairment.

  2017cites this paper
• Neuroprotective Epigenetic and DNA Damage Repairing Molecular Mechanisms of L-Carnitine and its Congeners against Aging and Age-Related Neurodegenerative Diseases

  2017cites this paper
• 16 L-carnitine in Hyperammonemia and Hepatic Encephalopathy

  2017cites this paper
• l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug

  2017cites this paper
• RETRACTED ARTICLE: Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

  2017cites this paper
• Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia

  2016cites this paper
• Cats in Positive Energy Balance Have Lower Rates of Adipose Gain When Fed Diets Containing 188 versus 121 ppm L-Carnitine

  2016cites this paper
• Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT)

  2016cites this paper
• l-Carnitine improves cognitive and renal functions in a rat model of chronic kidney disease.

  2016cites this paper
• Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid.

  2016cites this paper
• Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study

  2016cites this paper
• I'd Do Anything for Research, But I Won't Do That: Interest in Pharmacological Interventions in Older Adults Enrolled in a Longitudinal Aging Study

  2016cites this paper
• Cognitive remission: a novel objective for the treatment of major depression?

  2016cites this paper
• NOVEL TARGETS FOR MITOCHONDRIAL DYSFUNCTION FOLLOWING TRAUMATIC BRAIN INJURY

  2016cites this paper
• Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria

  2016cites this paper
• ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats

  2015cites this paper
• Roundoc Rx: Mild Cognitive Impairment and Memory Loss

  2015cites this paper
• Medical Foods and Dietary Approaches in Cognitive Decline, Mild Cognitive Impairment, and Dementia

  2015cites this paper
• Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

  2015cites this paper
• Prevention of Cognitive Impairment in the Midlife Women

  2015cites this paper
• Pharmacokinetic comparisons of two acetyl-L-carnitine formulations in healthy Korean volunteers.

  2015cites this paper
• Dietary interventions as a neuroprotective therapy for the delay of the onset of cognitive decline in older adults: an umbrella review protocol

  2015cites this paper
• Targeting Mitochondria for Healthy Brain Aging

  2015cites this paper
• Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study

  2015cites this paper
• Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology

  2015cites this paper
• Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: effect of l-acetylcarnitine and relationships with Dementia and Depression pathophysiology.

  2015cites this paper
• A review on the role of l-carnitine in the management of tamoxifen side effects in treated women with breast cancer

  2014cites this paper
• Prophylactic role of acetyl-l-carnitine on knee lesions and associated pain in a rat model of osteoarthritis.

  2014cites this paper
• Bioactive Compounds in Meat and their Functions

  2014cites this paper
• Characterization of in vitro models for evaluation of molecular mechanisms involved in the action of Acetyl-L-Carnitine

  2014cites this paper
• Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

  2014cites this paper
• Acetyl-L-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation.

  2014cites this paper
• Decreased Cerebrospinal Fluid Levels of L-Carnitine in Non-Apolipoprotein E4 Carriers at Early Stages of Alzheimer's Disease

  2014cites this paper
• Functional Foods and Nutraceuticals: Potential Role in Human Health

  2014cites this paper
• Use of L-Carnitine in Patients with Chronic Cerebral Ischemia

  2014cites this paper
• Influence of energy drink ingredients on mood and cognitive performance.

  2014cites this paper
• [L-carnitine treatment patients with chronic cerebral ischemia].

  2013cites this paper
• Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia

  2013cites this paper
• Metabolic agents and cognitive function

  2013cites this paper
• Stress oxydant et maladie d’Alzheimer

  2013cites this paper
• Decreased CSF levels of L-carnitine in non-apolipoprotein E 4 carriers at early stages of Alzheimer ́ s disease

  2013cites this paper
• Tributyrin May Have Practical Potential for Improving Cognition in Early Alzheimer ’ s Disease Via Inhibition of HDAC 2

  2013cites this paper
• Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond

  2013cites this paper